Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Information provided by:
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00187031
First received: September 12, 2005
Last updated: June 3, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given